Quantcast
Last updated on April 17, 2014 at 7:54 EDT

Latest Clinical trial Stories

2014-02-19 08:31:25

SAN DIEGO, Feb. 19, 2014 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, announced today that Dr. Rodney S. Markin has joined the Company's Board of Directors. Dr. Markin is a hepatic pathologist by training, and is a leading authority in the field of laboratory automation. (Logo: http://photos.prnewswire.com/prnh/20120620/LA28014LOGO) "We are very pleased that Rod has joined our board of directors" stated Antonius Schuh, Ph.D.,...

2014-02-18 23:25:00

Collaboration will create methodologies to drive improved decision-making in exploratory phase development. Reston, Virginia (PRWEB) February 18, 2014 Aptiv Solutions, a global biopharmaceutical and medical device development services company leading the adoption of innovative clinical trial approaches such as adaptive design, today announced that Novartis Pharma AG, Janssen Pharmaceuticals Inc, and Eli Lilly have joined them in co-founding the ADDPLAN DF Consortium. The members of the...

2014-02-18 23:01:28

Experts say the U.S. Supreme Court’s upholding of the individual mandate will benefit biomedical research. Since the Affordable Care Act just went into effect in January 2014, researchers will now see the benefits of the mandate upheld by the U.S. Supreme Court. San Antonio, TX (PRWEB) February 18, 2014 Texas Medical Research Associates, a clinical research facility, say that the Affordable Care Act, in effect as of Jan. 1, 2014, will have a positive impact on biomedical research. The...

2014-02-18 12:30:55

DURHAM, N.C., Feb. 18, 2014 /PRNewswire-iReach/ -- Health Decisions, Inc., the full-service clinical research organization of choice for forward-looking biopharma and medical device companies, today announced the appointment of Patrick Phillips, D Phil, as Vice President, Clinical Affairs. (Photo: http://photos.prnewswire.com/prnh/20140218/MN66379) "We are delighted to add a clinical affairs executive with outstanding capabilities, deep global experience and expertise in the...

2014-02-18 12:30:16

DALLAS, Feb. 18, 2014 /PRNewswire-iReach/ -- RnRMarketResearch.com adds "eClinical Solutions Market by Products (CDMS/EDC, CTMS, Ecoa , Randomization & Trial Supply Management, Safety), Services, Buyers (Pharma/Biopharma, CROS, Healthcare Providers) & Delivery Modes (Web Hosted, on-Premise, Cloud-Based) - Global Forecast to 2018" to its store. (Photo: http://photos.prnewswire.com/prnh/20140218/MN66207) The global eClinical solutions market is estimated to grow at a CAGR of...

2014-02-18 08:32:53

Third Phase of Collaboration Aims to Unravel Mysteries of Disease by Identifying Disease Markers and Potential New Drug Targets FRAMINGHAM, Mass. and SUNNYVALE, Calif., Feb. 18, 2014 /PRNewswire/ -- Berg and the Parkinson's Institute and Clinical Center today announced the next phase in their ongoing partnership, focused on identifying potential biomarkers that may lead to breakthroughs in the research, diagnosis, and treatment of Parkinson's disease. Using Berg's Interrogative...

2014-02-18 08:29:35

MELBOURNE, Australia and NEW YORK, Feb. 18, 2014 /PRNewswire/ -- Key Points: -- Primary endpoints of safety and tolerability met. -- Secondary endpoint: Statistically significant improvement in a measure of executive function(cognition) in research participants administered 250mg PBT2 daily (p=0.042). -- PBT2 250mg was also associated with a favourable signal in functional capacity. -- Preliminary evidence suggests PBT2 250mg reduced atrophy of...

2014-02-17 04:22:32

STIRLING, Scotland, February 17, 2014 /PRNewswire/ -- eClinicalHealth Limited, a technology and consulting company dedicated to the provision of innovative clinical trial solutions is proud to announce the appointment of one of the most distinguished experts in the field of applied innovation in clinical research to chair their Industry Advisory Board. Miguel Orri, a former Senior Director at Pfizer was previously responsible for Pfizer's REMOTE virtual clinical trial...

2014-02-14 23:25:48

More and more frequently, pharma companies are sending their research into less experienced countries and regions. Noted clinical trial statistician Dr. Johan Karlberg has collected and analyzed 7 years of industry-sponsored clinical trial data to help identify which countries and regions are the best choices for hosting clinical trials now, as well as the long-term outlook for multiyear studies. Falls Church, VA (PRWEB) February 14, 2014 Globalization of Industry-Sponsored Clinical...

2014-02-14 23:01:28

Results from Alpha BRAIN™ Pilot Study to Be Presented at the International Neuropsychological Society Annual Conference Austin, Texas (PRWEB) February 14, 2014 Results from a pilot study entitled “A Proof of Concept Study for a Randomized Double-Blind, Placebo Controlled, Parallel Group, Efficacy Study of Alpha BRAIN™ Administered Orally,” conducted by the Boston Center for Memory will be presented at the annual International Neuropsychological Society (INS) meeting in Seattle,...